- Home
- MDAI vs ATNM Comparison
MDAI vs ATNM Comparison
Compare MDAI & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAI
- ATNM
- Stock Information
- Founded
- MDAI 2013
- ATNM 2000
- Country
- MDAI United States
- ATNM United States
- Employees
- MDAI N/A
- ATNM N/A
- Industry
- MDAI Medical/Dental Instruments
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- MDAI Health Care
- ATNM Health Care
- Exchange
- MDAI Nasdaq
- ATNM Nasdaq
- Market Cap
- MDAI 55.9M
- ATNM 50.2M
- IPO Year
- MDAI N/A
- ATNM N/A
- Fundamental
- Price
- MDAI $1.33
- ATNM $1.30
- Analyst Decision
- MDAI Strong Buy
- ATNM Strong Buy
- Analyst Count
- MDAI 2
- ATNM 1
- Target Price
- MDAI $3.25
- ATNM $4.00
- AVG Volume (30 Days)
- MDAI 554.9K
- ATNM 337.0K
- Earning Date
- MDAI 11-11-2025
- ATNM 11-14-2025
- Dividend Yield
- MDAI N/A
- ATNM N/A
- EPS Growth
- MDAI N/A
- ATNM N/A
- EPS
- MDAI N/A
- ATNM N/A
- Revenue
- MDAI $23,168,000.00
- ATNM $90,000.00
- Revenue This Year
- MDAI N/A
- ATNM N/A
- Revenue Next Year
- MDAI $60.05
- ATNM N/A
- P/E Ratio
- MDAI N/A
- ATNM N/A
- Revenue Growth
- MDAI N/A
- ATNM 11.11
- 52 Week Low
- MDAI $1.01
- ATNM $1.03
- 52 Week High
- MDAI $3.25
- ATNM $2.41
- Technical
- Relative Strength Index (RSI)
- MDAI 24.84
- ATNM 44.33
- Support Level
- MDAI $1.38
- ATNM $1.23
- Resistance Level
- MDAI $1.55
- ATNM $1.60
- Average True Range (ATR)
- MDAI 0.13
- ATNM 0.09
- MACD
- MDAI -0.05
- ATNM 0.01
- Stochastic Oscillator
- MDAI 1.37
- ATNM 24.32
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.